脑部放疗，上午比下午敏感许多！
6 e( c* Y5 A( q/ p* t0 z& ~8 y( S4 A, X; k& N. E7 i; T
! u' ]! _; C; d" i, JCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
4 k6 n t; \4 K# W5 J7 l. W: {Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
& }2 ]# o8 F( _9 U" P7 ?- XRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
# w o9 A2 U0 wSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.+ S/ Z% u8 m8 J
+ {& F% D o) L! b. k
Abstract; V2 e& K, A7 s" ?6 N# u; {( p& d5 }6 @$ m/ f
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.5 h7 B5 H% z3 N6 A
5 m) V" O5 N+ J* RMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.$ o; K! x. l ]+ T" S
2 z, e4 `" Q6 G' g
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
6 b% `' C2 p. ?7 c
* {( M2 f% y+ i7 k3 kCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
6 t# O3 v$ {# R& P9 j( u$ ?
/ K2 g' Z$ m W7 v, d' x2 u |
1 M1 Q1 x8 }- h: \8 }
显身卡
